| Cell BioSciences Collects $15 Million Venture Capital |
|
|
| Wednesday, November 18, 2009 5:37:00 AM PDT | VentureDeal Staff |
Santa Clara, California -- Biotechnology company Cell Biosciences has landed $15 million for its fourth round of institutional venture capital investment.
Cell Biosciences says that it is focused on advancing protein research through the use of nanoproteomics to develop its capillary-based nano fluidic immunoassay platform.
Investors in the round included Domain Associates, Latterell Venture Partners, the Vertical Group, the Wellcome Trust, Novo A/S and other undisclosed investors. The company did not disclose how the funding proceeds would be used. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |